Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis
OBJECTIVESTo assess the cost-effectiveness of transarterial radioembolization (TARE) versus conventional transarterial chemoembolization (cTACE) and drug-eluting beads chemoembolization (DEE-TACE) for patients with unresectable early- to intermediate-stage hepatocellular carcinoma (HCC).DESIGNA coho...
Saved in:
Published in | Journal of medical economics Vol. 26; no. 1; pp. 1061 - 1071 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
31.12.2023
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!